STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

EXEL EXELIXIS INCORPORATED StockScouter® Report

6

StockScouter® Score

EXELIXIS INCORPORATED, a mid cap growth company in the healthcare sector, is expected to slightly outperform the market over the next six months with less than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • The most recent quarterly earnings report higher than analysts’ consensus forecast. Positive
  • The ratio of EXEL’s forward price-to-earnings multiple to its estimated growth rate is below the average of comparably-sized companies in the StockScouter universe. Positive

 

Concerns

  • An executive, director or major shareholder sold a large number of shares recently. Negative
  • Shares are being sold by financial institutions. Slighlty negative for a large company like EXEL

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that mid cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 20% done.
Progress: 80% done.
Low
High

Core Model Grades

B
D
C
C

Previous Ratings

5
5
6